A Phase II, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerability and Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.
A Phase I, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerabilityand Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.
A Multicenter, Randomized, Double Blind, Placebo-controlled, Two-arm, Phase II Clinical study to evaluate Safety, Tolerability and Efficacy of Topical 1% AKP-11 in Atopic Dermatitis Participants.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.